1,212
Views
25
CrossRef citations to date
0
Altmetric
Systemic disease and Oral bacteria

The oral microflora in obesity and type-2 diabetes

, , , , , & show all
Article: 19013 | Received 19 Jun 2012, Accepted 01 Oct 2012, Published online: 30 Oct 2012

References

  • Catenacci V, Hill J, Wyatt H. The obesity epidemic. Clin Chest Med. 2009; 30: 415–44. 10.3402/jom.v4i0.19013.
  • Pischon N, Heng N, Bernimoulin J, Kleber BM, Willich SN, Pischon T. Obesity, inflammation and periodontal disease. J Dent Res. 2007; 86: 400–9. 10.3402/jom.v4i0.19013.
  • Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock N, Magness S, et al.. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in the mouse. PLoS One. 2010; 5: e12191. 10.3402/jom.v4i0.19013.
  • Membrez M, Blancher F, Jaquet M, Biblioni R, Cani PD, Burcelin RG, et al.. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008; 22: 2416–26. 10.3402/jom.v4i0.19013.
  • Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al.. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57: 1470–81. 10.3402/jom.v4i0.19013.
  • Benson S, Kattoor J, Wegner A, Hammes F, Reidick D, Grigoleit JS, et al.. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain. 2012; 153: 794–9. 10.3402/jom.v4i0.19013.
  • Krogh-Madsen R, Plomgaard P, Moller K, Mittendorfer B, Pedersen BK. Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol Endocrinol Metab. 2006; 291: E108–E14. 10.3402/jom.v4i0.19013.
  • Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al.. Selective increases of Bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia. 2007; 50: 2374–83. 10.3402/jom.v4i0.19013.
  • Kondo S, Xiao J-Z, Satoh T, Odamaki T, Takahashi S, Sugahara H, et al.. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci Biotechnol Biochem. 2010; 74: 1656–61. 10.3402/jom.v4i0.19013.
  • Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Human gut microbes associated with obesity. Nature. 2006; 444: 1022–3. 10.3402/jom.v4i0.19013.
  • Haffajee AD, Socransky SS. Relation of body mass index, periodontitis and Tannerella forsythia. J Clin Periodontol. 2009; 36: 89–99. 10.3402/jom.v4i0.19013.
  • Goodson JM, Groppo D, Halem S. Carpino E. Is obesity an oral bacterial disease?. J Dent Res. 2009; 88: 519–23. 10.3402/jom.v4i0.19013.
  • Zeigler C, Persson G, Wondimu B, Marcus C, Sobko T, Modeer T. Microbiota in the oral sub-gingival biofilm is associated with obesity in adolescence. Obesity. 2012; 20: 157–64. 10.3402/jom.v4i0.19013.
  • Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, et al.. Molecular characterization of the faecal microbiota in patients with type II diabetes. Curr Microbiol. 2010; 61: 69–78. 10.3402/jom.v4i0.19013.
  • Dandona P, Weinstock R, Thusdu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998; 83: 2907–10. 10.3402/jom.v4i0.19013.
  • Engebretson S, Chertog R, Nichols A, Hey-Hadavi J, Celenti R, Grbic J. Plasma levels of tumor necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol. 2007; 34: 18–24. 10.3402/jom.v4i0.19013.
  • Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obesity Surg. 2005; 15: 474–81. 10.3402/jom.v4i0.19013.
  • NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991; 115: 956–61.
  • Culnan DM, Cooney RN, Stanley B, Lynch CJ. Apolipoprotein A-IV, a putative satiety/anti-atherogenic factor, rises after gastric bypass. Obesity. 2009; 17: 46–52. 10.3402/jom.v4i0.19013.
  • Guo X, Xia X, Tang R, Zhou J, Zhao H, Wang K. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol. 2008; 47: 367–73. 10.3402/jom.v4i0.19013.
  • Haakensen M, Dobson CM, Deneer H, Ziola B. Real-time PCR detection of bacteria belonging to the Firmicutes Phylum. Int J Food Microbiol. 2008; 125: 236–41. 10.3402/jom.v4i0.19013.
  • Matsuki TK, Watanabe J, Fujimoto Y, Miyamoto T, Takada K, Matsumoto K, et al.. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol. 2002; 68: 5445–51. 10.3402/jom.v4i0.19013.
  • Liu C, Song Y, McTeague M, Vu AW, Wexler H, Finegold SM. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. FEMS Microbiol Lett. 2003; 222: 9–16. 10.3402/jom.v4i0.19013.
  • Yoshida A, Nagashima S, Ansai T, Tachibana M, Kato H, Watari H, et al.. Loop-mediated isothermal amplification method for rapid detection of the periodontopathic bacteria Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola. J Clin Microbiol. 2005; 43: 2418–24. 10.3402/jom.v4i0.19013.
  • Dridi B, Henry M, El Khechine A, Raoult D, Drancouort M. High prevalence of Methanobrevibacter smithii and Methanospaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One. 2009; 4: 1–6. 10.3402/jom.v4i0.19013.
  • Motulsky H. Intuitive Biostatistics. Oxford University Press. New York, 1995
  • Page R, Eke P. Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 2007; 78: 1387–99. 10.3402/jom.v4i0.19013.
  • Nelson KE, Fleischmann RD, DeBoy RT, Paulsen IT, Fouts DE, Eisen JA, et al.. Complete genome sequence of the oral pathogenic bacterium Porphyromonas gingivalis strain W83. J Bacteriol. 2003; 185: 5591–601. 10.3402/jom.v4i0.19013.
  • Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al.. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA. 2009; 106: 2365–70. 10.3402/jom.v4i0.19013.
  • Furet JP, Kong LC, Tap J, Poitou C, Basdevamt A, Bouillot JL, et al.. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss. Diabetes. 2010; 59: 3049–57. 10.3402/jom.v4i0.19013.
  • Li J, Ashrafian H, Bueter M, Kinross J, Sands C, LeRoux C, et al.. Metabolic surgery profoundly influences gut microbial-host metabolic cross talk. Gut. 2011; 60: 1214–23. 10.3402/jom.v4i0.19013.
  • Lee C, Adler A, Sandhu MS, Sharp S, Forouhi N, Ergou S, et al.. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia. 2009; 52: 1040–7. 10.3402/jom.v4i0.19013.
  • Cottam DR, Schaffer PA, Shaftan GW, Velcu L, Angus LDG. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obesity Surg. 2002; 12: 335–42. 10.3402/jom.v4i0.19013.
  • Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000. 2005; 38: 135–87. 10.3402/jom.v4i0.19013.
  • Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004; 28: 405–40. 10.3402/jom.v4i0.19013.
  • Park M, Kim M, Ji G. Assessment of lipopolysaccharide-binding activity of Bifidobacterium and its relationship with cell surface hydrophobicity, autoaggregation, and inhibition of interleukin-8 production. J Microbiol Biotechnol. 2007; 17: 1120–6.